13F-HR filed by Birchview Capital, LP
Birchview Capital, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 20:57:39 UTC, with 79 holding rows worth $173,107,278.
- Accession
- 0001618205-26-000005
- Filer
- CIK 1618205
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 79 entries on the cover page, a total value of $173,107,278 stated on the cover page (in dollars after the unit check, H1), rows summing to $173,107,278 with VALUE read as dollars as filed, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KLA CORP | 482480100 | COM | 166,938 | $32,541,224 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 224,245 | $13,992,888 | dollars as filed | |
| Lam Research Corporation | 512807306 | COM | 30,000 | $9,855,300 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 286,804 | $8,555,362 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 55,200 | $6,360,696 | dollars as filed | |
| OVINTIV INC | 69047Q102 | COM | 107,500 | $6,215,650 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 373,671 | $5,616,275 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 715,955 | $5,176,355 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 35,000 | $4,931,150 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 449,019 | $3,762,779 | dollars as filed | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 33,351 | $3,681,950 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 138,000 | $3,588,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 25,190 | $3,572,950 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 171,000 | $3,445,650 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 281,365 | $3,393,262 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 46,000 | $2,785,070 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 226,992 | $2,537,771 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 93,380 | $2,518,459 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC | 21217B950 | PUT | 3,500 | $2,275,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 21,000 | $2,079,420 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 9,000 | $2,032,920 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 50,000 | $2,026,000 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 52,000 | $1,979,120 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 30,000 | $1,977,300 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 57,200 | $1,853,852 | dollars as filed | |
| EQT CORP COM | 26884L109 | Stock | 34,619 | $1,681,099 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,575,000 | $1,638,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 42,995 | $1,598,984 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 408,100 | $1,538,537 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 25,000 | $1,472,000 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 430,000 | $1,376,000 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 2,500 | $1,354,725 | dollars as filed | |
| FREEPORT MCMORAN INC CL B | 35671D857 | Stock | 18,027 | $1,261,919 | dollars as filed | |
| QUINCE THERAPEUTICS INC COM | 22053A305 | Stock | 40,601 | $1,259,037 | dollars as filed | |
| Valneva SE ADR | 92025Y103 | COM | 201,390 | $1,245,597 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 18,741 | $1,233,158 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 55,600 | $1,195,956 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 6,000 | $1,106,340 | dollars as filed | |
| ANNEXON INC | 03589W952 | COM | 4,370 | $1,048,800 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 90,455 | $1,017,166 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 282,307 | $1,007,836 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 29,847 | $946,747 | dollars as filed | |
| QUIDEL CORP | 74838J101 | COM | 89,377 | $942,034 | dollars as filed | |
| BLOSSOMHILL THERAPEUTICS INC | 095130100 | COM | 50,000 | $932,000 | dollars as filed | |
| DISC MEDICINE INC | 254604951 | PUT | 450 | $841,500 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 22,935 | $814,881 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 15,400 | $767,228 | dollars as filed | |
| HARROW INC | 415858109 | COM | 24,000 | $739,200 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 176,432 | $649,270 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 224,918 | $602,780 | dollars as filed | |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 7,600 | $564,528 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 59,000 | $509,760 | dollars as filed | |
| CORMEDIX INC COM | 21900C308 | Stock | 65,874 | $507,230 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 120,000 | $484,800 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 90,700 | $476,175 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 160,964 | $460,357 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 24,000 | $457,920 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 36,220 | $423,774 | dollars as filed | |
| AETHLON MEDICAL INC | 00808Y703 | Common Stock, $0.001 par value per share | 62,837 | $409,697 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 200,000 | $382,000 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 160,000 | $379,200 | dollars as filed | |
| TRINITY CAP INC | 896442308 | COM | 20,000 | $351,000 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 30,000 | $327,900 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 20,000 | $307,000 | dollars as filed | |
| KAYNE ANDERSON BDC INC | 48662X105 | COM SHS | 20,000 | $251,200 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 60,296 | $249,625 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 36,849 | $233,991 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 21,917 | $203,828 | dollars as filed | |
| CARDIOL THERAPEUTICS INC | 14161Y200 | COM CL A | 100,000 | $166,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 20,450 | $156,852 | dollars as filed | |
| KAZIA THERAPEUTICS LTD | 68669G303 | SPONSORED ADS | 16,000 | $153,520 | dollars as filed | |
| KYNTRA BIO INC | 31572Q881 | COM NEW | 22,566 | $150,064 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 165,094 | $130,424 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 93,500 | $124,355 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 165,478 | $90,086 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 75,975 | $66,106 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 16,712 | $36,766 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 39,062 | $15,617 | dollars as filed | |
| BRISTOL-MYERS SQUIBB CO | 110122140 | RIGHT 12/30/2030 | 98,527 | $12,306 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001618205-26-000005 | this filing | 2026-11-13 |